총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Bellerophon Therapeutics, Inc. (BLPH), 포함 30 건 매수 및 19 건 매도. 내부자 매수 총액은 $5.96M 내부자 매도 총액은 $8.09M.
최근 활동이 있는 주요 내부자에는 Puissance Capital Management Lp, Puissance Life Science Opportunities Fund Vi, Bruder Scott P. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — BLPH
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2023-10-13 |
Puissance Capital Management Lp |
10 Percent Owner |
정보 매도 |
1,076,841 |
$0.10 |
$111.78K |
- |
| 2023-06-07 |
Puissance Life Science Opportunities Fund Vi |
10 Percent Owner |
정보 매도 |
134,421 |
$0.83 |
$111.57K |
1,076,841 |
| 2023-06-07 |
Bruder Scott P |
Director |
RSU 반환 |
14,607 |
$0.83 |
$12.07K |
14,607 |
| 2023-06-07 |
Fernandes Peter |
See Remarks |
RSU 반환 |
100,000 |
$0.83 |
$82.64K |
100,000 |
| 2023-06-07 |
Dekker Martin |
See Remarks |
RSU 반환 |
50,000 |
$0.83 |
$41.32K |
50,000 |
| 2023-06-07 |
Amin Naseem |
Director |
RSU 부여 |
47,578 |
- |
- |
291,865 |
| 2023-06-07 |
Cloyd Mary Ann |
Director |
RSU 반환 |
14,607 |
$0.83 |
$12.07K |
14,607 |
| 2023-06-07 |
Shah Parag Suresh |
VP of Business Operations |
RSU 반환 |
50,000 |
$0.83 |
$41.32K |
50,000 |
| 2023-06-07 |
Wang Theodore T |
Director |
RSU 반환 |
14,607 |
$0.83 |
$12.07K |
14,607 |
| 2023-06-07 |
Teufel Crispin |
Director |
RSU 반환 |
14,607 |
$0.83 |
$12.07K |
14,607 |
| 2023-06-07 |
Kim Bobae |
VP Reg. Affairs & Quality |
RSU 반환 |
50,000 |
$0.83 |
$41.32K |
50,000 |
| 2023-05-18 |
Puissance Life Science Opportunities Fund Vi |
10 Percent Owner |
정보 매도 |
560,000 |
$9.46 |
$5.3M |
1,211,262 |
| 2023-05-18 |
Kim Bobae |
VP Reg. Affairs & Quality |
옵션 행사 (매도) |
266 |
$7.35 |
$1.96K |
- |
| 2023-03-30 |
Kim Bobae |
VP Reg. Affairs & Quality |
처분 |
50,000 |
$1.52 |
$76K |
- |
| 2023-02-10 |
Bruder Scott P |
Director |
RSU 부여 |
29,000 |
$1.52 |
$44.08K |
29,000 |
| 2023-02-10 |
Fernandes Peter |
Chief Executive Officer |
RSU 부여 |
100,000 |
$1.52 |
$152K |
100,000 |
| 2023-02-10 |
Dekker Martin |
VP of Engineering & Manufactur |
RSU 부여 |
50,000 |
$1.52 |
$76K |
50,000 |
| 2023-02-10 |
Amin Naseem |
Director |
RSU 부여 |
84,000 |
- |
- |
244,287 |
| 2023-02-10 |
Cloyd Mary Ann |
Director |
RSU 부여 |
29,000 |
$1.52 |
$44.08K |
29,000 |
| 2023-02-10 |
Shah Parag Suresh |
VP of Business Operations |
RSU 부여 |
50,000 |
$1.52 |
$76K |
50,000 |
| 2023-02-10 |
Wang Theodore T |
10 Percent Owner |
RSU 부여 |
29,000 |
$1.52 |
$44.08K |
29,000 |
| 2023-02-10 |
Teufel Crispin |
Director |
RSU 부여 |
29,000 |
$1.52 |
$44.08K |
29,000 |
| 2023-02-10 |
Laccona Nicholas |
Financial Officer, (pfo & Pao) |
RSU 부여 |
50,000 |
$1.52 |
$76K |
50,000 |
| 2022-12-09 |
Fernandes Peter |
Principal Executive Officer |
RSU 원천징수 |
9,985 |
$0.93 |
$9.29K |
22,515 |
| 2022-12-09 |
Dekker Martin |
VP of Engineering & Manufactur |
RSU 원천징수 |
7,834 |
$0.93 |
$7.29K |
17,666 |
| 2022-12-09 |
Shah Parag Suresh |
VP of Business Operations |
RSU 원천징수 |
7,834 |
$0.93 |
$7.29K |
17,666 |
| 2022-12-09 |
Laccona Nicholas |
Financial Officer, (pfo & Pao) |
RSU 원천징수 |
5,530 |
$0.93 |
$5.14K |
12,470 |
| 2022-01-26 |
Fernandes Peter |
Chief Regulatory & Safety Offr |
RSU 부여 |
65,000 |
- |
- |
65,000 |
| 2022-01-26 |
Dekker Martin |
VP of Engineering & Manufactur |
RSU 부여 |
51,000 |
- |
- |
51,000 |
| 2022-01-26 |
Shah Parag Suresh |
VP of Business Operations |
RSU 부여 |
51,000 |
- |
- |
51,000 |
| 2022-01-26 |
Laccona Nicholas |
Financial Officer, (pfo & Pao) |
RSU 부여 |
36,000 |
- |
- |
36,000 |
| 2021-12-31 |
Bruder Scott P |
Director |
RSU 부여 |
21,828 |
$3.10 |
$67.67K |
36,966 |
| 2021-12-31 |
Amin Naseem |
Director |
RSU 부여 |
8,671 |
$3.10 |
$26.88K |
23,809 |
| 2021-12-31 |
Cloyd Mary Ann |
Director |
RSU 부여 |
21,828 |
$3.10 |
$67.67K |
36,300 |
| 2021-12-31 |
Wang Theodore T |
10 Percent Owner |
RSU 부여 |
21,828 |
$3.10 |
$67.67K |
35,634 |
| 2021-12-31 |
Teufel Crispin |
Director |
RSU 부여 |
21,828 |
$3.10 |
$67.67K |
33,087 |
| 2021-09-30 |
Laccona Nicholas |
Controller, (pfo & Pao) |
처분 |
1,500 |
$10.12 |
$15.18K |
- |
| 2021-06-07 |
Puissance Life Science Opportunities Fund Vi |
10 Percent Owner |
RSU 부여 |
8,189 |
$4.00 |
$32.76K |
1,771,262 |
| 2021-04-26 |
Puissance Life Science Opportunities Fund Vi |
10 Percent Owner |
RSU 부여 |
380,950 |
$12.00 |
$4.57M |
380,950 |
| 2021-03-31 |
Peacock Jonathan M |
Director |
RSU 부여 |
15,308 |
- |
- |
157,033 |
| 2021-03-18 |
New Mountain Investments Ii, Llc |
10 Percent Owner |
정보 매도 |
400,000 |
$5.48 |
$2.19M |
609,231 |
| 2020-09-10 |
Fares Wassim |
Officer |
알 수 없음 |
- |
- |
- |
- |
| 2020-09-10 |
Bennett Matthew |
Director |
RSU 부여 |
6,509 |
$10.12 |
$65.87K |
6,509 |
| 2020-09-10 |
Bruder Scott P |
Director |
RSU 부여 |
6,509 |
$10.12 |
$65.87K |
15,138 |
| 2020-09-10 |
Moura Andre V. |
Director |
RSU 부여 |
6,509 |
$10.12 |
$65.87K |
13,472 |
| 2020-09-10 |
Amin Naseem |
Director |
RSU 부여 |
6,509 |
$10.12 |
$65.87K |
15,138 |
| 2020-09-10 |
Cloyd Mary Ann |
Director |
RSU 부여 |
6,509 |
$10.12 |
$65.87K |
14,472 |
| 2020-09-10 |
Wang Theodore T |
10 Percent Owner |
RSU 부여 |
6,509 |
$10.12 |
$65.87K |
13,806 |
| 2020-09-10 |
Teufel Crispin |
Director |
RSU 부여 |
6,509 |
$10.12 |
$65.87K |
11,259 |
| 2020-09-10 |
Fares Wassim |
Chief Medical Officer |
정보 매수 |
4,000 |
$10.18 |
$40.71K |
4,000 |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료